Navigation Links
Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose
Date:10/6/2010

Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From... -- EVRY, France, October 6, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Alternative Energies, Gas, Oil & Energy, Green Technology, Biotechnology, Chemical, New Products & Services Click to view news release full screen  

Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose

 

EVRY, France, October 6, 2010 /PRNewswire/ -- Global Bioenergies, located on the Genopole campus at Evry (France), announces the first prototype of its manufacturing process for the biological production of isobutene. It relies on the use of a bacterial strain harboring an artificial metabolic pathway created by the company.

Global Bioenergies announces that it has reached a key milestone in the development of its process for the transformation of renewable resources into gaseous isobutene (also called isobutylene or methylpropene). An initial series of bacterial strains were developed that can produce isobutene by transforming glucose.

Marc Delcourt, co-founder and CEO of the company, states, "We have achieved our goal to bioproduce isobutene in vivo ahead of target. We are now concentrating our efforts on increasing both the rate and scale of fermentation. We plan to carry out pilot plant tests prior to the industrial exploitation of the process. This phase will require new financial investment."

Philippe Marliere, co-founder and designer of the process, adds, "We have taught a bacterium to convert glucose to isobutene through an entirely novel process. The metabolic layout that we established passes by 3-hydroxy-isovalerate (also called 3-hydroxy-3-methylbutyrate). This chemical intermediate, which is absent from natural bacteria is, in turn, enzymatically converted into isobutene in our strains. The process is set up in accordance with the patent application filed in July 2008."

Jean-Marc Paris, professor at the EcoleSuperieure de Physique et de Chimie (Paris Tech) and a member of the Scientific Advisory Board, concludes, "This is the first time that an artificial metabolic pathway, which leads the production of a light olefin from renewable resources, has been designed and assembled in a micro-organism. These results set a precedent for the in-depth changes which the worldwide chemical industry will have to undergo in the 21st century."

Fuels, as well as a variety of polymers, representing a global market of $29b, can be manufactured from isobutene. Global Bioenergies is now focused on repeating this success with other molecules of the light olefin family, such as ethylene and propylene, each one associated with markets greater than $100b.

http://www.global-bioenergies.com

Press and public relations:

Benedicte.Robert@global-bioenergies.com - Phone: +33-1-64-98-20-50


'/>"/>
SOURCE Global Bioenergies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ground Zero Pharmaceuticals Announces Expansion of Global Consulting in Somatic Cell Therapies
2. Reportlinker Adds Global Synthetic Biology Industry
3. Reportlinker Adds Global Soft Tissue Allografts Industry
4. Reportlinker Adds Cancer Profiling and Pathways: Technologies and Global Markets
5. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
6. Diagenode Releases Two New Epigenetic Monoclonal 5-hmC Antibodies for Quantifying Global Hydroxymethylation
7. Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview
8. Medix Uses Globalpark to Glean Insights From Over 20,000 Opinion Leaders
9. Chiasma to Present at the UBS Global Life Sciences Conference
10. Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference
11. Keryx Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Cell therapies for a range ... by research at Worcester Polytechnic Institute (WPI) that yielded a newly patented method ... , The novel method, developed by WPI faculty members Raymond Page, PhD, professor ...
(Date:5/24/2016)... ... May 24, 2016 , ... Last week, Callan Capital, an ... and entrepreneurs, held The Future of San Diego Life Science event at the Estancia ... science community attended the event with speakers Dr. Rich Heyman, former CEO of Aragon ...
(Date:5/23/2016)... ... , ... The need for blood donations in South Texas and across the nation is growing. ... Tissue Center, blood donations are on the decline. In fact, donations across the country are ... in South Texas in the last four years alone. , There is no substitute for ...
(Date:5/23/2016)... Ind. , May 23, 2016 Zimmer Biomet ... musculoskeletal healthcare, today announced that its Board of Directors has ... for the second quarter of 2016. The ... or about July 29, 2016 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):